期刊文献+

颈动脉支架植入与药物治疗对脑梗死合并认知功能障碍的对比研究 被引量:2

Comparative study of underwent carotid stent implantation and drug therapy in patients with cerebral infarction combined cognitive impairment
下载PDF
导出
摘要 目的探究颈动脉支架植入术对脑梗死合并认知功能障碍患者支架植入后认知功能的影响。方法选取有认知功能障碍的脑梗死患者80例,在常规治疗的基础上,将有适应证的45例患者行颈动脉支架血管成形术(支架组),未行支架治疗的35例患者给予药物治疗(药物组)。在治疗前及治疗后1、3、6个月应用简易精神状态检查量表(MMSE)、蒙特利尔认知功能量表(Mo CA)、日常生活能力量表(Barthel指数)来观察认知功能的变化。结果经治疗6个月的药物组和手术后1、3、6个月的支架组在MMSE、Mo CA评分及Barthel指数明显提高,与治疗前相比有统计学意义(P<0.05);支架组MMSE、Mo CA评分及Barthel指数较药物组相比亦有明显提高,两者相比有统计学意义(P<0.05)。结论颈动脉支架植入术可改善脑梗死合并认知功能障碍患者的认知功能障碍。 Objective To study the influence of cognitive impairment of underwent carotid stent implantation in patients with cerebral infarction combined cognitive impairment. Methods Of the 80 patients with cerebral infarction combined cognitive impairment, based on the routine treatment, 45 patients with indication in stent group were treated with underwent carotid stent transluminal angioplasty, and the other 35 patients in drug group were treated with drug therapy. To observe the changes of cognitive function by mini mental state examination(MMSE), Montreal cognitive function scale(Mo CA), daily living measuring scale(Barthel index) before treatment and treatment after 1, 3, 6 months. Results The MMSE, Mo CA score, and Barthel index in drug group after treatment 6 months and in stent group after operation 1, 3, 6 months were obviously increased compared with before treatment, the differences was statistically significant(P〈0.05), and which in stent group was obviously increased compared with which in drug group, the differences was statistically significant(P〈0.05). Conclusion Underwent carotid stent implantation could improve the cognitive impairment in patients with cerebral infarction combined cognitive impairment.
出处 《中国医药科学》 2015年第18期7-11,共5页 China Medicine And Pharmacy
基金 河南省医学科技攻关项目(200802013)
关键词 颈动脉支架置入 药物治疗 脑梗死认知功能障碍 对比研究 Underwent carotid stent implantation Drug therapy Cerebral infarction combined cognitive impairment Comparative study
  • 相关文献

参考文献22

  • 1Kastrup A, Ernemann U, Nagele T, et al.Risk factors for early recurrent cerebral ischemia before treatment of symptomatic carotid stenosis[J].Stroke, 2006,37 : 3032-3034.
  • 2张微微,李小刚,王默力,彭丹涛,郭力,蔡晓杰,陈飞,李莹,黄勇华.奥拉西坦治疗卒中后认知功能障碍的有效性及安全性[J].中华神经科杂志,2013,46(7):489-493. 被引量:51
  • 3郑纪平,赵伟丽,李国丽.老年急性脑梗死合并脑白质疏松症患者的认知功能障碍研究[J].临床和实验医学杂志,2014,13(2):106-109. 被引量:13
  • 4陈娜,陆连生,宋巧,康梅,卢海丽,史万英,李玉萍.通心络胶囊辅治腔隙性脑梗死合并血管性认知功能障碍患者疗效观察[J].疑难病杂志,2014,13(10):1054-1057. 被引量:3
  • 5Cheng HL, Lin C J, Song BW, et al.Impairments in cognhitive function and brain connectivity in severe asymptomatic carotid stenosis[J].Stroke, 2012,43 : 2567- 2573.
  • 6Grueter BE, Schulz UG.Age-related cerebral white matter disease ( leukoaraiosis ) : a review[J].Postgrad M.ed J, 2012,88: 79-87.
  • 7Barnett HJ.Carotid disease and cognitive dysfunction[J]. Ann Intern Med,2004,140: 303-304.
  • 8Gottesman RF, Grega MA, Bailey MM, et al.Association between hypotension, low ejection fraction and cogniti~,e performance in cardiac patients[J].Behav Neurol, 2010,22: 63-71.
  • 9Hattori Y, Okamoto Y, Nagatsuka K, et al.SIRT1 attenuates severe ischemic damage by preserving cerebral blood flow[J].Neuroreport, 2015,26 ( 3 ) : 113-117.
  • 10Joh nston SC, O Meara ES, Manollo TA, et al.Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease[J].Ann Intern Med,2004, 140: 237-247.

二级参考文献49

  • 1贾建平.重视血管性认知障碍的早期诊断和干预[J].中华神经科杂志,2005,38(1):4-6. 被引量:265
  • 2舒凯,席桂发,牛洪泉,董震,于家省,雷霆,李龄.奥拉西坦胶囊治疗颅脑外伤的临床评价[J].中华神经医学杂志,2005,4(5):474-476. 被引量:15
  • 3刘治军,胡欣.促智药奥拉西坦的临床和基础研究[J].中华神经外科疾病研究杂志,2005,4(3):286-288. 被引量:69
  • 4吴以岭.中医络病学说与心脑血管疾病[M].北京:中国科学技术出版社,2001.7.
  • 5中华医学会神经病学分会痴呆与认知障碍学组写作组.血管性认知障碍诊治指南[J].中华神经科杂志,2011,.
  • 6Elias MF, Sullivan LM, D' Agostino RB, et al. Framingham stroke risk profile and lowered cognitive performance. Stroke, 2004,35 : 404-409.
  • 7Seshadri S, Wolf PA, Beiser A, et al. Stroke risk profile, brain volume,and cognitive function:the Framingham Offspring Study. Neurology ,2004,63 : 1591-1599.
  • 8Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and poststroke dementia: a systematic review and meta-analysis. Lancet Neuro1,2009,8 : 1006-1018.
  • 9Magot A, Desal H, Wiertlewski S, et al. Dural arteriovenous fistula. A rare cause of treatable dementia. Rev Neurol ( Paris ), 2004, 160:425-433.
  • 10Zekry D, Hauw JJ, Gold G. Mixed dementia: epidemiology, diagnosis, and treatment. J Am Geriatr Soc,2002,50 : 1431-1438.

共引文献64

同被引文献30

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部